First Manhattan’s ResMed RMD Stock Holding History

First Manhattan’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20	Closed	-$3.96K	–	1161
2024 Q1	$3.96K	Buy	20 +19	+1,900%	+$3.48K	﹤0.01%	1222
2023 Q4	$172	Buy	+1	New	+$154	﹤0.01%	1401
2023 Q1	–	Sell	-21	Closed	-$4.37K	–	1672
2022 Q4	$4.37K	Buy	+21	New	+$4.61K	﹤0.01%	1434
2021 Q3	–	Sell	-20	Closed	-$4K	–	1662
2021 Q2	$4K	Buy	+20	New	+$4.21K	﹤0.01%	1440
2020 Q4	–	Sell	-60	Closed	-$10K	–	1394
2020 Q3	$10K	Buy	+60	New	+$11.1K	﹤0.01%	1128
2020 Q1	–	Sell	-1,000	Closed	-$154K	–	1441
2019 Q4	$154K	Hold	1,000	–	–	﹤0.01%	729
2019 Q3	$135K	Hold	1,000	–	–	﹤0.01%	757
2019 Q2	$122K	Hold	1,000	–	–	﹤0.01%	782
2019 Q1	$103K	Hold	1,000	–	–	﹤0.01%	821
2018 Q4	$113K	Hold	1,000	–	–	﹤0.01%	778
2018 Q3	$115K	Hold	1,000	–	–	﹤0.01%	821
2018 Q2	$103K	Hold	1,000	–	–	﹤0.01%	813
2018 Q1	$98K	Buy	+1,000	New	+$94.5K	﹤0.01%	806
2014 Q4	–	Sell	-800	Closed	-$39K	–	1518
2014 Q3	$39K	Buy	+800	New	+$40.7K	﹤0.01%	1009

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Manhattan's RMD Position: Q2 2024 in Review

First Manhattan sold out of ResMed (RMD) in Q2 2024, closing a stake of 20 shares — an estimated $3.96K sold.

First Manhattan first reported a position in RMD in Q3 2014 and held it in 14 quarters. The position peaked at $154K in Q4 2019. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

First Manhattan reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 20 ResMed shares in Q2 2024, an estimated $3.96K.
First Manhattan first reported a position in ResMed in Q3 2014 and held it in 14 quarters.
First Manhattan's ResMed position peaked at $154K in Q4 2019.
771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.